URBASON Side Effects

6044050-0 | Body Height Abnormal, Osteoporosis, Pituitary-dependent Cushing's Syndrome, Rash, Rheumatoid Arthritis, Weight Increased
on Dec 03, 2008 Female patient from GERMANY , 16 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Urbason (View Usage). Patient experienced the following unwanted or unexpected effects: body height abnormal, osteoporosis (What is osteoporosis?), pituitary-dependent cushing's syndrome, rash (What is rash?), rheumatoid arthritis (What is rheumatoid arthritis?), weight increased. Urbason dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ).

6028629-8 | Body Height Abnormal, Impaired Healing, Osteoporosis, Pituitary-dependent Cushing's Syndrome, Rash, Rheumatoid Arthritis, Weight Increased
Patient was taking Urbason (View Usage). Patient had the following side effects: body height abnormal, impaired healing, osteoporosis (What is osteoporosis?), pituitary-dependent cushing's syndrome, rash (What is rash?), rheumatoid arthritis (What is rheumatoid arthritis?), weight increased on Dec 03, 2008 from GERMANY Additional patient health information: Female patient , 16 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Urbason dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ).

5693245-4 | Abscess, Abscess Drainage, Anaemia, Blood Cholesterol Increased, Blood Creatinine Increased, Diabetes Mellitus, Kidney Transplant Rejection, Proteinuria, Pyrexia
Adverse event was reported on Mar 26, 2008 by a Male patient taking Urbason (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: SPAIN , 53 years of age, After Urbason was administered, patient had the following side effects: abscess (What is abscess?), abscess drainage, anaemia, blood cholesterol increased, blood creatinine increased, diabetes mellitus, kidney transplant rejection, proteinuria, pyrexia. During the same period patient was treated with CERTICAN (1.25 Mg, Bid) (View Certican Review and Certican Label ), NEORAL (175 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized and became disabled.

5650659-6 | Abscess, Abscess Drainage, Anaemia, Blood Cholesterol Increased, Blood Creatinine Increased, Diabetes Mellitus, Kidney Transplant Rejection, Proteinuria, Pyrexia
on Feb 25, 2008 Male patient from SPAIN , 53 years of age, was diagnosed with renal transplant and was treated with Urbason (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), abscess drainage, anaemia, blood cholesterol increased, blood creatinine increased, diabetes mellitus, kidney transplant rejection, proteinuria, pyrexia. Urbason dosage: . During the same period patient was treated with CERTICAN (1.25 Mg, Bid) (View Certican Review and Certican Label ), NEORAL (175 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized and became disabled.


5151426-2 | Haematoma Evacuation, Haemoglobin Decreased, Haemorrhage, Perineal Haematoma, Post Procedural Haemorrhage, Suture Insertion, Wound Dehiscence
on Nov 30, 2005 Male patient from GERMANY , 50 years of age, weighting 142.4 lb, was diagnosed with renal transplant and was treated with Urbason (View Usage). Patient had the following side effects: haematoma evacuation, haemoglobin decreased, haemorrhage, perineal haematoma, post procedural haemorrhage, suture insertion, wound dehiscence. Urbason dosage: 250 Mg Daily Dose. During the same period patient was treated with CERTICAN (No Treatment) (View Certican Review and Certican Label ), HEPARIN (View Heparin Review and Heparin Label ), MYFORTIC (360 Mg, Bid) (View Myfortic Review and Myfortic Label ), NEORAL (300 Mg Daily) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4613557-2 | Sepsis
Patient was taking Urbason (View Usage). After Urbason was administered, patient had the following side effects: sepsis (What is sepsis?) on Mar 15, 2005 from Additional patient health information: Male patient , 71 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Urbason dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

4558392-9 | Brain Oedema, Headache, Hyperparathyroidism Tertiary, Hypertensive Crisis, Low Turnover Osteopathy, Malaise, Regurgitation Of Food, Somnolence
Adverse event was reported on Nov 04, 2004 by a Female patient taking Urbason (View Usage) (Dosage: 10 Mg, Qd) was diagnosed with immunosuppression, renal transplant and. Location: , 33 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: brain oedema, headache (What is headache?), hyperparathyroidism tertiary, hypertensive crisis, low turnover osteopathy, malaise, regurgitation of food, somnolence. During the same period patient was treated with IMUREK (View Imurek Review and Imurek Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BELOC ZOK (1 Df, Bid) (View Beloc Zok Review and Beloc Zok Label ), UNAT (View Unat Review and Unat Label ), LONOLOX (View Lonolox Review and Lonolox Label ), CLEXANE /GFR/ (View Clexane /gfr/ Review and Clexane /gfr/ Label ), SANDIMMUNE (125 Mg, Bid) (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.